DANIELLE KIZZIE: Open Payments
NPI 1780460592 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 39 payments from 16 companies in 2025. Trend: 2023 $47 · 2024 $483 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $208 |
| AstraZeneca Pharmaceuticals LP | 6 | $110 |
| ABBVIE INC. | 4 | $81 |
| Novo Nordisk Inc | 4 | $65 |
| Corcept Therapeutics | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| SANOFI PASTEUR INC. | 1 | $19 |
Products named: CAPLYTA, Korlym, LEQVIO, QULIPTA, GVOKE HYPOPEN, UBRELVY, INSPIRE, ZENPEP.
Industry payments across CO — which companies pay providers there.
